Close Menu

NEW YORK (GenomeWeb) – After several extensions, Abbott completed its tender offer to purchase all outstanding shares of Alere's Series B convertible perpetual preferred stock at $402 per share.

The offer was made in connection with Abbott's acquisition of Alere, which was completed on Tuesday. The offer expired at 11:59 p.m. the same day.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.